Home Cart 0 Sign in  

[ CAS No. 4915-06-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 4915-06-4
Chemical Structure| 4915-06-4
Structure of 4915-06-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4915-06-4 ]

Related Doc. of [ 4915-06-4 ]

Alternatived Products of [ 4915-06-4 ]

Product Details of [ 4915-06-4 ]

CAS No. :4915-06-4 MDL No. :MFCD03410206
Formula : C5H2BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :VWVGOXGBMHAFFK-UHFFFAOYSA-N
M.W : 171.98 Pubchem ID :708670
Synonyms :

Calculated chemistry of [ 4915-06-4 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 31.12
TPSA : 36.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.63
Log Po/w (XLOGP3) : 2.06
Log Po/w (WLOGP) : 1.91
Log Po/w (MLOGP) : 0.27
Log Po/w (SILICOS-IT) : 1.95
Consensus Log Po/w : 1.56

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.67
Solubility : 0.371 mg/ml ; 0.00215 mol/l
Class : Soluble
Log S (Ali) : -2.46
Solubility : 0.59 mg/ml ; 0.00343 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.54
Solubility : 0.491 mg/ml ; 0.00286 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.54

Safety of [ 4915-06-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4915-06-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4915-06-4 ]
  • Downstream synthetic route of [ 4915-06-4 ]

[ 4915-06-4 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 4915-06-4 ]
  • [ 1899-24-7 ]
Reference: [1] Patent: US4332952, 1982, A,
  • 2
  • [ 1899-24-7 ]
  • [ 4915-06-4 ]
YieldReaction ConditionsOperation in experiment
85% With tert.-butylhydroperoxide; ammonium acetate; iodine; sodium carbonate In ethanol at 50℃; for 4.5 h; In a 25 mL two-necked round bottom flask equipped with a thermometer and a magnetic stirrer4mmol5-bromofuran-2-carbaldehyde (1-18), 6 mmol of NH4OAc, 4 mmol of Na2CO3, 4.4 mmol of TBHP, 0.1 mmol of I2, 5 mL of absolute ethanol Solvent, and then the reaction flask was placed in an oil bath preheated to 50 ° C and opened with a magnetic stirrer for 4.5 h. reaction The solution was stirred by adding sodium thiosulfate solution and then extracted with ether. The organic layer was separated and the solvent was evaporated under reduced pressure. The elution was carried out with a mixture of ethyl acetate / petroleum ether in a volume ratio of 1: 100 as an eluent, and the eluate containing the target compound was collected And the solvent was evaporated to give 5-bromofuran-2-carbonitrile with an isolated yield of 85percent.
82% With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium perchlorate; acetic acid; lithium hexamethyldisilazane In acetonitrile for 15 h; Electrochemical reaction General procedure: Preparative electrolysis experiments were performed using 263 APotentiostat/Galvanostat (Princeton Applied Research, USA). 0.1 MNaClO4–CH3CN solution (10 mL) containing aldehydes (1 mmol),TEMPO (0.1 mmol), HMDS (2.5mmol) and AcOH (2.5mmol) was electrolyzedwith stirring in an undivided cell (30 mL) equipped with twoplatinum sheets as anode (1.5 cm2) and cathode (3.0 cm2) respectivelyat a constant potential of 1.5 V vs Ag/Ag+ (0.1MAgNO3 in acetonitrile).The electrode separation was 1 cm. When the reaction was finished,10mL of saturatedNa2SO3 solution was added into the reactionmixtureand stirred for 15 min. Then the mixture was extracted with CH2Cl2(20 mL × 3). The organic layer was dried with anhydrous Na2SO4 andconcentrated in a rotary evaporator. The productswere obtained via purificationof column chromatography and their structures were confirmedby 1H NMR, 13C NMR and MS. NMR was performed on a BrukerAvance III spectrometer. GC-MS was performed on the Thermo TraceISQ instrument with TG 5MS capillary column.
Reference: [1] Chemistry of Heterocyclic Compounds, 2002, vol. 38, # 5, p. 524 - 529
[2] Advanced Synthesis and Catalysis, 2016, vol. 358, # 7, p. 1157 - 1163
[3] RSC Advances, 2017, vol. 7, # 3, p. 1484 - 1489
[4] Electrochimica Acta, 2017, vol. 226, p. 53 - 59
[5] Patent: CN106748881, 2017, A, . Location in patent: Paragraph 0050
[6] Electrochemistry Communications, 2016, vol. 64, p. 51 - 55
[7] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1986, vol. 22, # 2, p. 140 - 145[8] Khimiya Geterotsiklicheskikh Soedinenii, 1986, vol. 22, # 2, p. 181 - 186
[9] Patent: EP1792613, 2007, A2, . Location in patent: Page/Page column 46
[10] Angewandte Chemie - International Edition, 2015, vol. 54, # 14, p. 4241 - 4245
  • 3
  • [ 4465-70-7 ]
  • [ 4915-06-4 ]
YieldReaction ConditionsOperation in experiment
70% With [RhCl2(p-cymene)]2 In acetonitrile for 3 h; Reflux To a solution of aldoxime 4 (2.90 g, 15.26mmol) in CH3CN(30 mL) were added [RuCl2(p-cymene)]2 (0.28g, 0.46mmol).The reaction mixture was refluxed for 3 h. After removal of solvent under reducedpressure, the residue was purified by silica gelchromatography with petroleum ether/EtOAc (5:1) to afford 5 as a colorless oil (1.84 g, 70percent).1H NMR (300 MHz, CDCl3) δ 7.06 (1H, d, J = 3 Hz), 6.48 (1H, d, J= 3 Hz).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 2, p. 216 - 220
[2] Patent: WO2005/82899, 2005, A1, . Location in patent: Page/Page column 28-29
  • 4
  • [ 6134-61-8 ]
  • [ 4915-06-4 ]
Reference: [1] Patent: WO2010/45006, 2010, A1, . Location in patent: Page/Page column 41-42
[2] Patent: WO2017/176961, 2017, A1, . Location in patent: Paragraph 00695
  • 5
  • [ 1899-24-7 ]
  • [ 67-56-1 ]
  • [ 4915-06-4 ]
Reference: [1] Catalysis Science and Technology, 2016, vol. 6, # 20, p. 7429 - 7436
  • 6
  • [ 6134-61-8 ]
  • [ 4915-06-4 ]
Reference: [1] Patent: US4332952, 1982, A,
  • 7
  • [ 585-70-6 ]
  • [ 4915-06-4 ]
Reference: [1] Patent: WO2017/176961, 2017, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4915-06-4 ]

Bromides

Chemical Structure| 123837-09-2

[ 123837-09-2 ]

2-Bromo-5-methylfuran

Similarity: 0.82

Chemical Structure| 1899-24-7

[ 1899-24-7 ]

5-Bromofuran-2-carbaldehyde

Similarity: 0.69

Chemical Structure| 585-70-6

[ 585-70-6 ]

5-Bromofuran-2-carboxylic acid

Similarity: 0.58

Chemical Structure| 3199-50-6

[ 3199-50-6 ]

1-(5-Bromofuran-2-yl)ethanone

Similarity: 0.58

Chemical Structure| 2527-99-3

[ 2527-99-3 ]

Methyl 5-bromofuran-2-carboxylate

Similarity: 0.55

Nitriles

Chemical Structure| 617-90-3

[ 617-90-3 ]

2-Furonitrile

Similarity: 0.74

Chemical Structure| 41717-32-2

[ 41717-32-2 ]

1-Benzofuran-2-carbonitrile

Similarity: 0.56

Chemical Structure| 212197-74-5

[ 212197-74-5 ]

5-Cyanofuran-2-carboxylic acid

Similarity: 0.52

Chemical Structure| 118449-57-3

[ 118449-57-3 ]

3-(4-Bromophenoxy)propanenitrile

Similarity: 0.51

Chemical Structure| 31518-13-5

[ 31518-13-5 ]

3,4-Dihydro-2H-pyran-6-carbonitrile

Similarity: 0.50

Related Parent Nucleus of
[ 4915-06-4 ]

Furans

Chemical Structure| 123837-09-2

[ 123837-09-2 ]

2-Bromo-5-methylfuran

Similarity: 0.82

Chemical Structure| 617-90-3

[ 617-90-3 ]

2-Furonitrile

Similarity: 0.74

Chemical Structure| 1899-24-7

[ 1899-24-7 ]

5-Bromofuran-2-carbaldehyde

Similarity: 0.69

Chemical Structure| 585-70-6

[ 585-70-6 ]

5-Bromofuran-2-carboxylic acid

Similarity: 0.58

Chemical Structure| 3199-50-6

[ 3199-50-6 ]

1-(5-Bromofuran-2-yl)ethanone

Similarity: 0.58